Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
Sponsor: AbbVie
Summary
Atrophic acne scars are flat, indented or with an inverted center scars that develop at the endpoint of the normal healing process for acne. Acne scarring that remains after acne resolves has a significant impact on health related quality of life, including reduced self-esteem and embarrassment/self consciousness. ELAPR002f provides an immediate space-occupying effect for filling in the scar tissue. The purpose of this study is to assess how safe and effective ELAPR002f injectable gel is on adult participants with atrophic acne scars. ELAPR002f injectable gel is an investigational device being developed for the treatment of facial atrophic acne scars. There are 2 cohorts in this study. In Cohort 1, all participants will receive ELAPR002f injectable gel. In Cohort 2, participants are placed in 1 of 2 groups, called treatment arms. Each group receives a different treatment. There is a 1 in 4 chance that participants will be assigned to the saline active control group. Around 395 adult participants with moderate to severe atrophic acne scarring on both cheeks will be screened in the study in approximately 25 sites in the United States. Participants will receive 3 treatments over 2 months of intradermal injections of either ELAPR002f injectable gel or saline active control and will be followed for up to an additional 12 months. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Official title: A Multicenter, Cohort-design, Double-blind, Randomized, Parallel-group, Controlled Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
Key Details
Gender
All
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
395
Start Date
2025-10-24
Completion Date
2029-11
Last Updated
2025-11-24
Healthy Volunteers
No
Conditions
Interventions
ELAPR002f Injectable Gel
Intradermal Injections
Saline Control
Intradermal Injections
Locations (10)
Advanced Research Associates - Glendale /ID# 254961
Glendale, Arizona, United States
Marcus Facial Plastic Surgery /ID# 275880
Redondo Beach, California, United States
Pacific Clinical Innovations /ID# 256185
Vista, California, United States
DMR Research PLLC /ID# 256199
Westport, Connecticut, United States
Hamilton Research, LLC /ID# 256925
Alpharetta, Georgia, United States
Aesthetic Center at Woodholme /ID# 256197
Baltimore, Maryland, United States
The Center for Dermatology Cosmetics & Laser Surgery /ID# 256182
Mount Kisco, New York, United States
Wilmington Dermatology Center /ID# 256192
Wilmington, North Carolina, United States
Austin Institute for Clinical Research - Pflugerville /ID# 256200
Pflugerville, Texas, United States
SkinDC /ID# 254962
Arlington, Virginia, United States